ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,828.36
0.15%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evaxion Biotech AS (EVAX)

  7. Evaxion Biotech AS (EVAX) News

Evaxion Biotech AS (EVAX)

Evaxion Biotech AS
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EVAX
DateTimeSourceHeadlineSymbolCompany
28/05/202414:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
28/05/202413:21GlobeNewswire Inc.Evaxion Announces Business Update and First Quarter 2024 Financial ResultsNASDAQ:EVAXEvaxion Biotech AS
24/05/202421:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
23/05/202422:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
23/05/202422:00GlobeNewswire Inc.Evaxion to Present New Positive Data from Ongoing Phase 2 Study on Lead Vaccine Candidate EVX-01 at the American Society of Clinical Oncology Annual Meeting 2024NASDAQ:EVAXEvaxion Biotech AS
10/05/202422:29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
10/05/202422:00GlobeNewswire Inc.Evaxion Receives Nasdaq NotificationNASDAQ:EVAXEvaxion Biotech AS
06/05/202422:01Edgar (US Regulatory)Form F-1 - Registration statement for certain foreign private issuersNASDAQ:EVAXEvaxion Biotech AS
17/04/202413:00GlobeNewswire Inc.Evaxion Announces Phase 2 Clinical Trial Update: First Patient Completed Dosing with Personalized Cancer Vaccine EVX-01NASDAQ:EVAXEvaxion Biotech AS
02/04/202412:00GlobeNewswire Inc.Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus InfectionNASDAQ:EVAXEvaxion Biotech AS
27/03/202411:30GlobeNewswire Inc.Evaxion Announces Business Update and Full Year 2023 Financial ResultsNASDAQ:EVAXEvaxion Biotech AS
19/03/202411:30GlobeNewswire Inc.Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ PlatformNASDAQ:EVAXEvaxion Biotech AS
29/02/202412:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
29/02/202412:30GlobeNewswire Inc.Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology InnovationsNASDAQ:EVAXEvaxion Biotech AS
20/02/202412:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
20/02/202412:30GlobeNewswire Inc.Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSDNASDAQ:EVAXEvaxion Biotech AS
07/02/202421:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
07/02/202413:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
07/02/202413:30GlobeNewswire Inc.Evaxion Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:EVAXEvaxion Biotech AS
06/02/202413:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
06/02/202413:30GlobeNewswire Inc.Evaxion Announces Closing of $15 Million Public OfferingNASDAQ:EVAXEvaxion Biotech AS
05/02/202414:09Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:EVAXEvaxion Biotech AS
05/02/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
02/02/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EVAXEvaxion Biotech AS
01/02/202414:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
01/02/202414:20GlobeNewswire Inc.Evaxion Biotech Announces Pricing of $15 Million Public OfferingNASDAQ:EVAXEvaxion Biotech AS
31/01/202422:10Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
31/01/202414:26Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
30/01/202420:16Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:EVAXEvaxion Biotech AS
26/01/202421:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:EVAXEvaxion Biotech AS
 Showing the most relevant articles for your search:NASDAQ:EVAX

Your Recent History

NYSE
TXU
Txu
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved